TransCode Therapeutics
NASDAQ: RNAZ
Healthcare
Biotechnology
Rank
#40191
Market Cap
8.34 M
Volume
1.79 M
Price
0.36
Change (%)
4.51%
Country or region
United States
United States
TransCode Therapeutics Stock Split History Overview
This company has undergone a total of three stock splits throughout its history. Three reverse splits occurred, consolidating shares and stabilizing stock prices. The most recent split occurred on May 15, 2025 with a ratio of 1-for-28. These adjustments reflect the company's strategic efforts to align stock performance with market conditions.
TransCode Therapeutics (NASDAQ: RNAZ) Stock Split History
| Date | Split Ratio | Multiple | Cumulative multiple | Type |
|---|---|---|---|---|
| May 15, 2025 | 1:28 | x0.035714287 | x5.411256E-05 | Reverse |
| December 4, 2024 | 1:33 | x0.030303031 | x0.0015151516 | Reverse |
| May 23, 2023 | 1:20 | x0.05 | x0.05 | Reverse |
Frequently Asked Questions
If TransCode Therapeutics (stock symbol: NASDAQ: RNAZ) had never undergone any stock splits, its price per share today would be approximately 0.00 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 1-for-28) that occurred on May 15, 2025.
TransCode Therapeutics (stock symbol: NASDAQ: RNAZ) has undergone a total of three stock splits. The most recent split occurred on May 15, 2025. One share bought prior to the first split on May 23, 2023 would now equal 0.00 shares.
TransCode Therapeutics (stock symbol: NASDAQ: RNAZ) has undergone three stock splits in its history. The most recent split, a 1-for-20 split, occurred on May 15, 2025. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.
